Hall SL - Search Results

1

Stem cell antigen-1+ cell-based bone morphogenetic protein-4 gene transfer strategy in mice failed to promote endosteal bone formation.

Hall SL, Chen ST, Gysin R, Gridley DS, Mohan S, Lau KH. Hall SL, et al. J Gene Med. 2009 Oct;11(10):877-88. doi: 10.1002/jgm.1369. J Gene Med. 2009. PMID: 19629966

2

An improved mouse Sca-1+ cell-based bone marrow transplantation model for use in gene- and cell-based therapeutic studies.

Hall SL, Lau KH, Chen ST, Felt JC, Gridley DS, Yee JK, Baylink DJ. Hall SL, et al. Acta Haematol. 2007;117(1):24-33. doi: 10.1159/000096785. Epub 2006 Nov 8. Acta Haematol. 2007. PMID: 17095856

3

Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice.

Hall SL, Lau KH, Chen ST, Wergedal JE, Srivastava A, Klamut H, Sheng MH, Gridley DS, Mohan S, Baylink DJ. Hall SL, et al. Mol Ther. 2007 Oct;15(10):1881-9. doi: 10.1038/sj.mt.6300258. Epub 2007 Jul 17. Mol Ther. 2007. PMID: 17637718 Free article.

4

Stem cell antigen-1 positive cell-based systemic human growth hormone gene transfer strategy increases endosteal bone resorption and bone loss in mice.

Hall SL, Chen ST, Wergedal JE, Gridley DS, Mohan S, Lau KH. Hall SL, et al. J Gene Med. 2011 Feb;13(2):77-88. doi: 10.1002/jgm.1542. J Gene Med. 2011. PMID: 21322098

5

Opposing effects of Sca-1(+) cell-based systemic FGF2 gene transfer strategy on lumbar versus caudal vertebrae in the mouse.

Lau KH, Chen ST, Wang X, Mohan S, Wergedal JE, Kesavan C, Srivastava AK, Gridley DS, Hall SL. Lau KH, et al. Among authors: hall sl. Gene Ther. 2016 Jun;23(6):500-9. doi: 10.1038/gt.2016.21. Epub 2016 Mar 2. Gene Ther. 2016. PMID: 26934099 Free PMC article.

6

The Roles and Mechanisms of Actions of Vitamin C in Bone: New Developments.

Aghajanian P, Hall S, Wongworawat MD, Mohan S. Aghajanian P, et al. J Bone Miner Res. 2015 Nov;30(11):1945-55. doi: 10.1002/jbmr.2709. Epub 2015 Oct 7. J Bone Miner Res. 2015. PMID: 26358868 Free PMC article. Review.

7

Calcitonin acutely increases tyrosyl-phosphorylation of proteins in human osteosarcoma (SaOS-2) cells.

Thomas A, Hall SL, Nicolas V, Lau KH, Farley JR. Thomas A, et al. Among authors: hall sl. Calcif Tissue Int. 1995 Apr;56(4):268-73. doi: 10.1007/BF00318045. Calcif Tissue Int. 1995. PMID: 7767836

8

Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.

Farley JR, Hall SL, Tarbaux NM. Farley JR, et al. Among authors: hall sl. Calcif Tissue Int. 1989 Oct;45(4):214-21. doi: 10.1007/BF02556040. Calcif Tissue Int. 1989. PMID: 2509008

9

Two biochemical indices of mouse bone formation are increased, in vivo, in response to calcitonin.

Farley JR, Hall SL, Herring S, Tarbaux NM. Farley JR, et al. Among authors: hall sl. Calcif Tissue Int. 1992 Jan;50(1):67-73. doi: 10.1007/BF00297300. Calcif Tissue Int. 1992. PMID: 1310883

10

The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation.

Farley JR, Tarbaux NM, Hall SL, Linkhart TA, Baylink DJ. Farley JR, et al. Among authors: hall sl. Endocrinology. 1988 Jul;123(1):159-67. doi: 10.1210/endo-123-1-159. Endocrinology. 1988. PMID: 3383771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters